ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМП10.25789/YMJ.2023.84.04ymj-270Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL RESEARCHГематологические показатели крови у жителей г. Якутска, переболевших коронавирусной инфекцией COVID-19Hematological blood parameters in residents of Yakutsk city recovered from coronavirus infection COVID-19КонстантиноваЛ. И.KonstantinovaL. I.

 Константинова Лена Ивановна – к.б.н., н.с.

Konstantinova  Lena Ivanovna – PhD in Biology, researcher

konstanta.l@mail.ruОхлопковаЕ. Д.OkhlopkovaE. D.

Охлопкова Елена Дмитриевна – к.б.н., с.н.с.

Okhlopkova Elena Dmitrievna – PhD, senior researcher

ОлесоваЛ. Д.OlesovaL. D.

Олесова Любовь Дыгыновна – к.б.н., в.н.с.– руковод. лаб.

Olesova  Lyubov Dygynovna – PhD, visiting scholar – head of the laboratory

ЯковлеваА. И.YakovlevaA. I.

 Яковлева Александра Ивановна – н.с.

Yakovleva Alexandra Ivanovna – PhD

МироноваЛ. В.MironovaL. V.

Миронова  Людмила Васильевна – зав. КДЛ Клиники ЯНЦ КМП.

Mironova Lyudmila Vasilyevna – Head of the Department, Clinical Diagnostic Laboratory of the YSC CMP Clinic

РомановаА. Н.RomanovaA. N.

Романова Анна Николаевна – д.м.н., директор

Romanova  Anna Nikolaevna – MD, Director

Якутский НЦ комплексных медицинских проблемРоссияYakut Science Center of Complex Medical ProblemsRussian Federation202306022025041620Copyright © Константинова Л.И., Охлопкова Е.Д., Олесова Л.Д., Яковлева А.И., Миронова Л.В., Романова А.Н., 20252025Константинова Л.И., Охлопкова Е.Д., Олесова Л.Д., Яковлева А.И., Миронова Л.В., Романова А.Н.Konstantinova L.I., Okhlopkova E.D., Olesova L.D., Yakovleva A.I., Mironova L.V., Romanova A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/270

Исследование посвящено сравнительному анализу результатов влияния коронавирусной инфекции COVID-19 на гематологические показатели крови у переболевших лиц после 3, 6, 9 и 12 мес. Мониторинг гематологических параметров важен для выявления и контроля пациентов, перенесших COVID-19 и нуждающихся в дополнительной помощи, и стратификации риска тяжелого течения заболевания. Исследование гематологических параметров показало, что средние показатели морфологического состава красной и белой крови у переболевших COVID-19 соответствуют общепринятым нормативам, за исключением тенденции к повышению моноцитов, базофилов, СОЭ и незначительному понижению показателей MCHC, что свидетельствует о недавно перенесенном инфекционном заболевании.

The study is devoted to a comparative analysis of the results of the effect of COVID-19 coronavirus infection on hematological blood parameters in patients who have been ill after three, six, nine and twelve months. Monitoring of hematological parameters is important for the identification and control of patients who have undergone COVID-19, who need additional assistance, and stratification of the risk of severe course of the disease. The study involved 161 residents of Yakutsk aged 20 to 72 years who had suffered COVID-19 in different periods of the pandemic. The study of hematological parameters showed that the average indicators of the morphological composition of red and white blood in people who have had COVID-19 correspond to generally accepted standards, with the exception of the tendency to increase monocytes, basophils, ESR and a slight decrease in MCHC indicators, which indicates a recently transmitted infectious disease

коронавирусная инфекцияCOVID-19SARS-CoV-2гематологические показатели кровиcoronavirus infectionCOVID-19SARS-CoV-2blood testhematological parameters of bloodReferencesДинамика содержания тромбоцитов в периферической крови в разные сроки постковидного периода / Ф.Х. Низамов [и др.] // Медицинская наука и образование Урала. 2023. Т. 24, № 3. С. 72-74.Dynamics of platelet content in peripheral blood in different periods of the postcovid period / F.H. Nizamov [et al.] // Medical science and education of the Urals. 2023. Vol. 24. No. 3. P. 72-74.Козлов И.А., Тюрин И.Н. Сердечно-сосудистые осложнения COVID 19 // Вестник анестезиологии и реаниматологии. 2020. Т. 17 (4). С. 14-22. https://doi.org/10.21292/2078-5658-2020-17-4-14-22.Kozlov I.A., Tyurin I.N. Cardiovascular complications of COVID 19 // Bulletin of Anesthesiology and Resuscitation. 2020. Vol. 17 (4). P. 14-22. https://doi.org/10.21292/2078-5658-2020-17-4-14-22.Профилактика, диагностика и лечение новой коронавирусной инфекции (СOVID-19). Временные методические рекомендации. Версия 1 (29.01.2020). Утв. Минздравом России.Prevention, diagnosis and treatment of new coronavirus infection (With OVID-19). Temporary methodological recommendations. Version 1 (29.01.20). Approved by the Ministry of Health of Russia.Cвязь показателей общего анализа крови с тяжестью течения COVID-19 у госпитализированных пациентов / Н.С. Губенко [и др.] // Южно-Российский журнал терапевтической практики. 2021. Т. 2 (1). С. 90-101.The relationship of the indicators of the general blood test with the severity of the course of COVID-19 in hospitalized patients / N.S. Gubenko [et al.] // South-Russian Journal of Therapeutic Practice. 2021. 2 (1). P. 90-101.Autoimmune haemolytic anaemia associated with COVID-19 infection / G. Lazarian [et al.] // Br J Haematol. 2020 Jul. 190 (1). P. 29-31. doi: 10.1111/bjh.16794.Autoimmune haemolytic anaemia associated with COVID-19 infection / G. Lazarian [et al.] // Br J Haematol. 2020 Jul. 190 (1). P. 29-31. doi: 10.1111/bjh.16794.Biomarkers associated with COVID-19 disease progression. G. Ponti [et al.] / Crit Rev Clin Lab Sci. 2020 Sep. 57 (6). P. 389-399. doi: 10.1080/10408363.2020.1770685.Biomarkers associated with COVID-19 disease progression. G. Ponti [et al.] / Crit Rev Clin Lab Sci. 2020 Sep. 57 (6). P. 389-399. doi: 10.1080/10408363.2020.1770685.Changes of hematological and immunological parameters in COVID-19 patients / X. Yuan [et al.] // Int J Hematol. 2020 Oct. 112 (4). P. 553- 559. doi: 10.1007/s12185-020-02930-w.Changes of hematological and immunological parameters in COVID-19 patients / X. Yuan [et al.] // Int J Hematol. 2020 Oct. 112 (4). P. 553- 559. doi: 10.1007/s12185-020-02930-w.Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis / A.J. Rodriguez-Morales [et al.] // Travel Med Infect Dis. 2020 Mar-Apr. 34:101623. doi: 10.1016/j.tmaid.2020.101623.Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis / A.J. Rodriguez-Morales [et al.] // Travel Med Infect Dis. 2020 Mar-Apr. 34:101623. doi: 10.1016/j.tmaid.2020.101623.Gajendra S. Spectrum of hematological changes in COVID-19. Am J Blood Res. 2022 Feb 15. 12 (1). P. 43-53.Gajendra S. Spectrum of hematological changes in COVID-19. Am J Blood Res. 2022 Feb 15. 12 (1). P. 43-53.Hematological findings and complications of COVID-19 / E. Terpos [et al.] // Am J Hematol. 2020 Jul. 95 (7). P. 834-847. doi: 10.1002/ajh.25829.Hematological findings and complications of COVID-19 / E. Terpos [et al.] // Am J Hematol. 2020 Jul. 95 (7). P. 834-847. doi: 10.1002/ajh.25829.Hematologic parameters in patients with COVID-19 infection / B.E. Fan [et al.] // Am J Hematol. 2020 Jun. 95 (6). P. E131-E134. doi: 10.1002/ajh.25774.Hematologic parameters in patients with COVID-19 infection / B.E. Fan [et al.] // Am J Hematol. 2020 Jun. 95 (6). P. E131-E134. doi: 10.1002/ajh.25774.Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020 Apr-Jun. 42 (2). P. 116-117. doi: 10.1016/j.htct.2020.03.001.Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020 Apr-Jun. 42 (2). P. 116-117. doi: 10.1016/j.htct.2020.03.001.Liu X, Zhang R, He G. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol. 2020 Jul. 99 (7). P. 1421-1428. doi: 10.1007/s00277-020-04103-5.Liu X, Zhang R, He G. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol. 2020 Jul. 99 (7). P. 1421-1428. doi: 10.1007/s00277-020-04103-5.Post-acute COVID 19 syndrome / Nalbandian A. [et al.] // Nat. Med. 2021. 27. P. 601-615. https://doi.org/10.1038/s41591-021-01283-z.Post-acute COVID 19 syndrome / Nalbandian A. [et al.] // Nat. Med. 2021. 27. P. 601-615. https://doi.org/10.1038/s41591-021-01283-z.Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak [Internet]. Wellcome; 2020 Jan 31. URL: https://wellcome.org/coronavirus-covid-19/open-data.Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak [Internet]. Wellcome; 2020 Jan 31. URL: https://wellcome.org/coronavirus-covid-19/open-data.The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clinical chemistry and laboratory medicine / M. Montagnana [et al.] // 2011. 50(4). P. 635– 641. DOI: 10.1515/cclm.2011.831.The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clinical chemistry and laboratory medicine / M. Montagnana [et al.] // 2011. 50(4). P. 635– 641. DOI: 10.1515/cclm.2011.831.Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study / L. Tan [et al.] // Med. 2020. 1(1). P. 128–138. DOI: 10.1016/j.medj.2020.05.002.Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study / L. Tan [et al.] // Med. 2020. 1(1). P. 128–138. DOI: 10.1016/j.medj.2020.05.002.

The authors declare that there are no conflicts of interest present.